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ulcer type IC.
Materials and Methods: We retrospectively collected 14 ulcer type IC
female patients, who were diagnosed during cystoscopic hydrodistension,
and their medical records were reviewed. The severity and duration of
symptoms, and self-assessed surgical responses were presented with
descriptive statistics.
Results: The mean age on the development of symptoms and on the
diagnosis were 56.0± 8.4 and 59.1± 7.0 years, respectively, with a mean
VAS pain score 8.2± 1.4. Ten (71.4%) patients received intravesical Botox
(botulinum toxin-A) injection with 50% (5 of 10) response rate of pain
relief; however, in 4 of 5 patients, their pain increased again after
2.75± 0.38 months. All patients received electrocauterization with 85.7%
(12 of 14) response rate; however, in 11 of 12 patients, their pain increased
again after 3.09± 1.75 months. Five patients with poor electro-
cauterization outcome received simple partial cystectomy; however, four
patients (80%) did not satisfy the surgical outcome due to rapid relapse of
pain after 1.75± 0.75 months. Two of these 4 patients subsequently
received extensive (supratrigonal) partial cystectomy concurrent with
augmentation enterocystoplasty (AE). Finally, total 6 patients received
extensive (supratrigonal) partial cystectomy concurrent with AE, and all
patients (100%) satisﬁed with the surgeries due to the signiﬁcant relief of
pain and symptoms during a follow-up of 7.67± 3.22 months.
Conclusion: For ulcer type IC patients, electrocauteterization as a treat-
ment option is effective but with short term efﬁcacy and a high relapse
rate. Simple partial cystectomy is not feasible in these patients. Extensive
partial cystectomy concurrent with AE can effectively relieve pain and
symptoms with high satisfaction.
PD12-4:
INTRAVESICAL BOTULINUMTOXIN-A INJECTIONS REDUCE BLADDER PAIN
OF INTERSTITIAL CYSTITIS/ BLADDER PAIN SYNDROME REFRACTORY TO
CONVENTIONAL TREATMENT e A PROSPECTIVE, MULTICENTER,
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL
Yuan-Hong Jiang, Hann-Chorng Kuo. Department of Urology, Buddhist Tzu
Chi General Hospital and Tzu Chi University Hualien, Taiwan
Purpose: Intravesical onabotulinumtoxinA (BoNT-A) injection is a bene-
ﬁcial treatment for interstitial cystitis/bladder pain syndrome (IC/BPS), yet
its therapeutic efﬁcacy remains to be validated. This study tests efﬁcacy
and safety of intravesical BoNT-A injections for treatment of IC/BPS.
Materials and Methods: A multicenter, randomized, double-blind, pla-
cebo-controlled trial in patientswith IC/BPS refractory to conventional
treatment was conducted. Patients were randomized in a 2:1 ratio to
hydrodistention plus suburothelial injections of BoNT-A 100U (Botox
group) or the equivalent amount of normal saline (N/S group). The primary
endpoint was a decrease in pain assessed using a visual analog scale (VAS)
at week 8 after treatment. Secondary endpoints included voiding diary and
urodynamic variables. The Wilcoxon sign rank and rank sum tests were
used for statistical analyses.
Results: A total of 60 patients (8 males, 52 females, age 50.8± 13.9 years)
including40 in theBotoxand20 in theN/Sgroupswere enrolled.Atweek8, a
signiﬁcantly greater reduction of pain was observed in the Botox group
compared to the N/S group (-2.6± 2.8 VS. -0.9± 2.2, p ¼ 0.021). The other
variables did not differ signiﬁcantly between groups except for cystometric
bladder capacitu, which was increased signiﬁcantly in the Botox group. The
overall success rates were 63% (26/40) in the Botox group and 15% (3/20) in
theN/S group (p¼ 0.028). Adverse events did not differ between the groups.
Conclusion: Intravesical Botox injection of 100U of BoNT-A effectively
reduced bladder pain symptoms in patients with IC/BPS. The adverse
events were acceptable.
PD12-5:
THE PREVALENCE OF NON-BLADDER COMORBIDITY BETWEEN
PATIENTS WITH INTERSTITIAL CYSTITIS / BLADDER PAIN SYNDROME
(IC/BPS) AND KETAMINE INDUCED UROPATHY (KIU)
Huei-Ching Wu1,2, Ming-Huei Lee 1,2, Wei-Chih Chen 1. 1Department of
Urology, Fong Yuan Hospital, Ministry of Health and welfare, Taiwan;
2Central Taiwan University of Science and Technology, TaiwanPurpose: Recreational ketamine abuse cause lower urinary tract symp-
toms including dysuria, urinary frequency, urgency, urge incontinence
and hematuria. Several reports showed denuded epithelial inﬂammation
of the bladder and petechial hemorrhage. As with similarly presenting
interstitial cystitis, several studies investigated the pathophysiology as
purinergic neurotransmission of ketamine induced uropathy. A recent
study found that patients with IC/BPS often have other non-bladder
conditions such as irritable bowel syndrome (IBS), ﬁbromyalgia (FM),
migraine headaches, and depression. The aim of this study is to investi-
gate subjective symptom score, voiding diary parameters he ﬁndings of
cystoscopic hydrodistension and presence of non-bladder condition
compared with IC/BPS patients.
Materials and Methods: This was a retrospective study. Of 24 patients
who were admitted due to severe lower urinary tract symptoms with
recreational ketamine abuse history more than one year and 173 female
patients who were compatible with AUA/SUFU criteria including un-
pleasant sensation (pain, pressure, discomfort) perceived to be related to
bladder with duration >6 weeks were included as control group. All of
patients with ketamine induced uropathy and IC/BPS patients were
assessed by cystoscopic hydrodistension and all of them have different
severity of glomerulations. These patients completed measures of pain
severity (Visual Analog Scale) and bladder symptom severity (IC Symptom
Index, IC Problem Index, The Pelvic Pain and Urinary/Frequency scale).
Three day voiding diary was also collected and all patients completed non-
bladder condition as medical history questionnaire including migraine,
FM, IBS, and depression. These data were analyzed using point bi-serial
correlation for association (ANOVA) and post-hoc analysis.
Results: The ketamine induced uropathy patients with a mean age of
26.58± 4.4 years were statistically signiﬁcant younger than IC/PBS patients
with a mean age of 44.26± 12.5 years (p<0.001). Patients with ketamine
induced uropathy had more severe pain score (p ¼ 0.01) and PUF score
(p¼0.005) than IC/BPSpatients. KIUhave signiﬁcant decrease of night-time
volume (p¼ 0.02) as well as increased day-time and night-time frequency.
Moreover, KIU have signiﬁcant decrease of anesthetic bladder capacity
during cystoscopic hydrodistension than IC/BPS patients (p<0.001). How-
ever, there were no differences in non-bladder condition between KIU and
IC/BPS patients (Table 1). After adjusted age between IC/BPS and KIU group,
there were still no differences in non-bladder condition (Table 2).
Conclusion: Subjective symptom scores, three day voiding diary param-
eters, and anesthetic bladder capacity in patients with KIC seem more
severe compare to those with IC/BPS. Compare to age matched IC/BPS,
there were no differences in non-bladder condition between KIU and IC/
BPS patients.
PD12-6:
CASE REPORT-BLADDER VOIDING STIMULATION TECHNEQUE CAUSE
VESICOURETERAL REFLUX
Wei-Hsuan Huang, Chieh-Lung Chou, Chao-Hsiang Chang. Department of
Urology, China Medical University Hospital, Taichung, Taiwan
Introduction: Neurogenic bladder is a dysfunction of the urinary bladder
due to disease of the central nervous system or peripheral nerves involved
in the control of micturition. Methods to improve bladder emptying
consist of two main strategies: to increase intravesical pressure and to
decrease outlet resistance. Textbook also mentioned that using trigger
technique such as tapping or scratching the skin above the pubis or
external genitalia, pulling the skin or hair of the pubis, scrotum, or thigh;
squeezing the clitoris; or by digital rectal stimulation, could induce bladder
reﬂexively to empty. Our patient had use this kind of technique but cause
VU reﬂux and hydronephrosis.
Case report: A 62-year-old male who was falling down from a tree(3m
height) developed T7 and T8 burst fracture. T7 complete paraplegia with
neurogenic bladder and neurogenic bowel were noted after surgery. CISC
was arranged for him. He had ICP 4 times/day plus suprapubic tapping and
Crede manuvar. and decreased residual urine amount after TURP+TUI. He
had regular OPD follow up and residual urine all around 100ml and renal
echo found no hydronephrosis. We had suggested him not to tapping and
had increase ICP frequency and add Anti-M drug.
However, Recurrent UTI and follow up renal echo found Bil. Hydro-
nephrosis, and Left hydroureter recently. We arrange VUDS for
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voiding sensation. Suprapubic tapping stimulation was given during
VUDS and found detrusor muscle contraction along with left VU reﬂux.
No detrusor overactivity, No obstruction, No Stress urinary incontinence
were found. We had suggested him to increase CISC frequency and not
tapping for voiding. Now patient condition was stable and CISD for about
500ml.
Discussion: Xiao et al. had found the reﬂex route that the L7 motor
axons, which regenerate into the S1 spinal nerve terminate in the pelvic
ganglia and synapse with bladder ganglion cells or that they project
into the bladder and communicate directly with the detrusor smooth
muscle. In this case, trigger technique stimulated the bladder detrusor
muscle contraction, but bladder sphincter do not open at the same time
cause VU reﬂux. Tai et al, had mentioned when bladder volume is large,
the bladder spinal reﬂex can drive the detrusor to generate very high
intravesical pressures necessary for voiding. However, at the same time
the bladder afferents can also drive the pudendal efferents to contract
the external urethra sphincter, which blocks voiding. J.J. Wyndaele et al
had follow up 105 SCI patients, Vesico-ureteral reﬂux was demon-
strated in four of the 18 patients who used trigger technique. S.J. Foley
et al considered the used of reﬂex voiding by suprapubic voiding is
discourage. Clare J. Fowler et al had mentioned that the SCI pt, just like
severe “dysfunctional voiding” will damage UB and upper urinary tract.
James Middleton also had mention that using the reﬂex voiding will
cause some late complication including vesico-reteric reﬂux, hydro-
nephrosis, pyolonephritis and deterioration of renal function. As this
case, we do not suggest to using suprapubic trigger technique.
Sphincter do not activate at the same time while detrusor muscle ac-
tivity increased anc cause high intravesicle pressure. VU reﬂux was
found and longterm prognosis is not good due to frequency VU reﬂux
and recurrent APN. We suggested this patient should stop using
detrusor stimulation technique and increase intermittent clean self-
catheterization frequency.
Conclusion: In this case, detrusor stimulation technique do really activate
the detursor muscle activity but cause VU reﬂux. Detrusor stimulation
technique do really activate the detursor activity in some kinds of SCI
patient but suitable or not need a larger number of cases with VUDS
survey. As our opinion, SCI patient should increase the frequency of
intermittent clean self catheterization and avoided using trigger tech-
nique.Podium-13
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PD13-1:
REDUCTION OF ENLARGED PROSTATE DECREASES THE INCIDENCE OF
INGUINAL HERNIA
Yu-Hua Fan 1,2,3, Hsiao-Jen Chung 1,2,3, Eric Yi-Hsiu Huang 1,2,3, Alex T.L.
Lin 1,2,3, Kuang-Kuo Chen 1,2,3. 1Department of Urology, Taipei Veterans
General Hospital, Taipei, Taiwan; 2 Shu-Tien Urological Research Center,
Taipei, Taiwan; 3 School of Medicine, National Yang-Ming University, Taipei,
Taiwan
Purpose: Patients with benign prostatic obstruction may need to strain to
void and this effort over time may have a direct impact on the abdominal
wall contributing to the development of inguinal hernia (IH). Furthermore,
the published data showed that patients with IH present higher intensity
of lower urinary tract symptoms. It is interesting to know whether tran-
surethral prostatectomy for benign prostatic hyperplasia (BPH) could
reduce the incidence of IH.
Materials and Methods: We recruited male patients who were newly
diagnosed with BPH and aged 50 years or older from a urology dataset
including 3,431,366 individuals selected from the National Health Insur-
ance Research Database for the year 2006 to 2010. According to treatment
strategies, patients were assigned to one of the following categories:
transurethral resection of prostate (TURP), a-1 blockers only, 5a-reductase
inhibitors ± a-1 blockers. All subjects were followed up to the end of 2010
or the development of IH. Patients were excluded if they had prostaticcancer, constipation, chronic obstructive pulmonary disease, or IH devel-
oped within 6 months of diagnosis of BPH. The age-adjusted cox time-
dependent model was used to calculate the risk of IH between different
treatment groups.
Results: We identiﬁed 171965 incident male patients with newly diag-
nosed BPH. Of the BPH patients, 8294 (4.82 %) underwent TURP (TURP
group), 151753 (88.25%) received a-1 blockers only (AB group), 11918
(6.93%) received 5a-reductase inhibitors plus a-1 blockers or not (5ARI
group). The incidences of IH in different treatment group were as follows:
93 (1.12%) in TURP group, 2334 (1.54%) in AB group, 147 (1.23%) in 5ARI
group. The incidence of IH in either TURP group or 5ARI group was
signiﬁcantly lower than that in AB group (both p < 0.001). There was no
difference in incidence rates of IH between TURP and 5ARI group. We
further subdivided the TURP group into two subgroups according the
weight of resected specimens and these were < 15 gm and  15 gm. There
was no difference in incidence rates of IH between the two subgroups of
TURP. No matter what the weight of the resected specimens, signiﬁcantly
lower incidence rates of IH than AB group were noted. Additionally, there
was no difference in incidence rates of IH between TURP < 15gm or > 15gm
and 5ARI group.
Conclusion: Regardless of the prostate size, TURP could signiﬁcantly
reduce the incidence of inguinal hernia in BPH patients compared with
pharmacological treatment with a-1 blockers only. Nevertheless, combi-
nation therapy with 5a-reductase inhibitors could provide the similar ef-
fect against IH.
PD13-2:
UROTHELIAL DYSFUNCTION AND SENSORY PROTEIN EXPRESSIONS IN
KETAMINE CYSTITIS e COMPARISION WITH INTERSTITIAL CYSTITIS
Jia-Fong Jhang, Hann-Chorng Kuo. Department of Urology, Buddhist Tzu Chi
General Hospital and Tzu Chi University, Hualien, Taiwan
Purpose: Ketamine related cystitis (KC) is a newly developed clinical
syndrome, and it has many similar characteristics with interstitial cystitis
(IC), such as bladder pain and urinayr frequency. Previous animal study
suggested urothelial dysfunction and abnormal sensory protein expression
might participate the pathogenesis of IC. Current study is designed to
investigate the urothelial function and protein expression in human KC
bladder and compare with IC bladder.
Materials and Methods: The KC and IC patients who were admitted to our
hospital for cystoscopic hydrodistentionwere enrolled into this study. Tirty
bladder random cold cup biopsies from KC bladder and thirty-two bladder
specimen for IC bladder were taken during cystoscopic hydrodistention,
and the specimenswere investigated for E-cadherin, zona occludens 1 (ZO-
1), tryptase, and TUNEL with immunoﬂuorescence staining and quantiﬁ-
cation. Specimens obtainedwere investigated formuscarinic receptorsM2,
M3, TGF-beta, b3, eNOS and P2X3 with Western blotting. Ten healthy
control bladder specimens were also investigated and compared with KC
bladder. The symptoms, duration of ketamine abuse and urodynamics
examination parameters in the KC patients were also analyzed.
Results: The KC bladder specimens showed signiﬁcantly lower expression
of E-cadherin and ZO-1, and higher expression of TUNEL and tryptase ac-
tivity than the control bladder specimens. M3 expression in KC bladder
was also signiﬁcantly increased than that in control subjectives. The
expression of M2, e-NOS, P2X3 and TGF- beta did not have difference
between KC bladder and control. The ketamine abuse history, visual
analogue scale pain score, cystometric bladder capacity and maximal
bladder capacity under anesthesia did not have signiﬁcant correlationwith
M2, M3, e-NOS and P2X3. When compared to IC bladder specimen, the KC
specimen had signiﬁcantly lower M2 and e-NOS expression. The b3 is
signiﬁcantly higher in KC than that in IC bladder. The E-cadherin, ZO-1,
tryptase, TUNEL, M3 and P2X3 expression had no signiﬁcant difﬁerence
between KC and IC specimen.
Conclusion: KC bladder tissue showed urothelial dysfunction, mast cell
mediated inﬂammation, increased apoptosis and increased muscarinic
receptors. These ﬁnding might participate the pathogenesis of KC. The
difference sensory and inﬂammatory protein between IC and KC might
imply different pathogenesis in the two disease.
